Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...

The company posted a net profit of Rs 852.6 crore in the quarter ended September in comparison to Rs 489.7 crore in the ...

(Photo: Company Website) Global pharma major Lupin Limited on Tuesday announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the ...

Lupin Q2 Results Live : Lupin declared their Q2 results on November 7, 2024, reporting a robust performance with a topline ...

Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...

Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

Lupin’s average revenue will potentially increase 9.2 per cent Y-o-Y to Rs 5,502 crore as against Rs 5,038 crore in Q2FY24.

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to treat Type II diabetes and obesity, Lupin top-brass said. This segment of ...

Warner Bros. Discovery is adapting the Harry Potter novels all over again – this time as a TV series – and it’s hard to ...

Food engineers have harnessed the power of lupins (legumes) to create a yogurt that rivals dairy in taste and texture while ...

CEO Vinita Gupta stated that Lupin expects to maintain a quarterly range of $220-230 million for its US business, driven by ...